FH-awareness week #3 – EAS Advanced Courses in FH. Deepening knowledge & creating networks
23 September 2015
September 24 is FH-awareness day. All this week we will focus on the disease Familial Hypercholesterolaemia (FH), aiming to increase the knowledge of this common inherited disease in both Europe and USA, and highlighting the great need for early detection and treatment.
During FH awareness week we will highlight resources and materials available from EAS to tackle FH. Today we look at EAS Advanced Courses in FH.
EAS Advanced Courses in FH – a programme of courses, soon to be extended Europe-wide
EAS has for some years now run Advanced Courses - educational activities for relatively small groups with the aim to offer Course attendees an opportunity:
- to deepen their theoretical skills and/or practical knowledge, which they can then apply in their own research or clinical practice
- to meet and discuss with experts in their own field
- to network and interact with their peers from other European countries
EAS has recently announced a 2-day Advanced Course on FH, to take place from Monday 30 November- Wednesday 02 December, 2015. The closing date for applications for places on this Course is Monday, September 28. [Application procedures & Application form.]
This Course will be held at the Sahlgrenska Hospital, University of Gothenburg, Sweden, directed by Olov Wiklund, and Stefano Romeo, of the University of Gothenburg. The faculty for Gothenburg Course comprises experts in the field, including.
- Alberico L. Catapano, Milan, Italy
- Thomas Freiberger, Prague, Czech Republic
- Gunnar Karlsson, Sweden (representing FH patients)
- Pedro Mata, Madrid, Spain
- Kausik Ray, London, UK
- Kjetil Retterstol, Oslo, Norway
- Stefano Romeo, Gothenburg, Sweden
- Handrean Soran, Manchester, UK
- Joep Defesche, Amsterdam, The Netherlands
- Antonio J. Vallejo-Vaz, London, UK
- Albert Wiegman, Amsterdam, The Netherlands
- Olov Wiklund, Gothenburg, Sweden
Topics featured in the Programme include:
- The prevalence and clinics of HeFH, HoFH
- FH and CVD
- Genetics of FH, mutations and mutation frequencies
- Diagnosis of FH: Scoring systems and genetic diagnosis, Polygenic causes of clinical FH
- Cascade screening introduction and experiences from two countries
- Treatment of FH: Diet, statin and statin intolerance
- The role of PCSK9 inhibitors and other emerging drugs
- Homozygous FH, apheresis
- FH in children
- The lipid clinic and organization of FH, the role of different participants in the team
- Presentation from FH patient society
- Presentation and discussion of cases
- Presentation of the EAS-FHSC initiative and the FH register
Coming to a city near you...?
Due to the high demand for places on this course, EAS plans to run similar courses on FH on an annual basis, in different European cities.
If your National Atherosclerosis Society is interested in co-hosting an EAS Advanced Course in FH, please contact the EAS Office.
Find out more